日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Effects of prednisolone tapering on effectiveness of infliximab in patients with ulcerative colitis: data from a retrospective cohort

泼尼松龙减量对英夫利昔单抗治疗溃疡性结肠炎患者疗效的影响:一项回顾性队列研究的数据

Ovesen, Pernille Dige; Attauabi, Mohamed; Ilvemark, Johan F K F; Wewer, Mads Damsgaard; Warren, David J; Burisch, Johan; Klaasen, Rolf A; Bolstad, Nils; Steenholdt, Casper; Seidelin, Jakob Benedict

Defining Transabdominal Intestinal Ultrasound Treatment Response and Remission in Inflammatory Bowel Disease: Systematic Review and Expert Consensus Statement

定义经腹肠道超声治疗炎症性肠病的反应和缓解:系统评价和专家共识声明

Ilvemark, Johan F K F; Hansen, Tawnya; Goodsall, Thomas M; Seidelin, Jakob B; Al-Farhan, Heba; Allocca, Mariangela; Begun, Jakob; Bryant, Robert V; Carter, Dan; Christensen, Britt; Dubinsky, Marla C; Gecse, Krisztina B; Kucharzik, Torsten; Lu, Cathy; Maaser, Christian; Maconi, Giovanni; Nylund, Kim; Palmela, Carolina; Wilson, Stephanie R; Novak, Kerri; Wilkens, Rune

Ulcerative Colitis and Acute Severe Ulcerative Colitis Patients Are Overlooked in Infliximab Population Pharmacokinetic Models: Results from a Comprehensive Review

英夫利昔单抗群体药代动力学模型忽视了溃疡性结肠炎和急性重症溃疡性结肠炎患者:一项综合综述的结果

Démaris, Alix; Widigson, Ella S K; Ilvemark, Johan F K F; Steenholdt, Casper; Seidelin, Jakob B; Huisinga, Wilhelm; Michelet, Robin; Aulin, Linda B S; Kloft, Charlotte

Influence of Genetics, Immunity and the Microbiome on the Prognosis of Inflammatory Bowel Disease (IBD Prognosis Study): the protocol for a Copenhagen IBD Inception Cohort Study

遗传、免疫和微生物组对炎症性肠病预后的影响(IBD预后研究):哥本哈根IBD初始队列研究方案

Attauabi, Mohamed; Madsen, Gorm Roager; Bendtsen, Flemming; Wewer, Anne Vibeke; Wilkens, Rune; Ilvemark, Johan; Vladimirova, Nora; Jensen, Annette Bøjer; Jensen, Frank Krieger; Hansen, Sanja Bay; Siebner, Hartwig Roman; Nielsen, Yousef Jesper Wirenfeldt; Møller, Jakob M; Thomsen, Henrik S; Thomsen, Simon Francis; Ingels, Helene Andrea Sinclair; Theede, Klaus; Boysen, Trine; Bjerrum, Jacob T; Jakobsen, Christian; Dorn-Rasmussen, Maria; Jansson, Sabine; Yao, Yiqiu; Burian, Ewa Anna; Møller, Frederik Trier; Fana, Viktoria; Wiell, Charlotte; Terslev, Lene; Østergaard, Mikkel; Bertl, Kristina; Stavropoulos, Andreas; Seidelin, Jakob B; Burisch, Johan

Infliximab clearance decreases in the second and third trimesters of pregnancy in inflammatory bowel disease

在炎症性肠病患者中,妊娠中期和晚期英夫利昔单抗的清除率会降低。

Grišić, Ana-Marija; Dorn-Rasmussen, Maria; Ungar, Bella; Brynskov, Jørn; Ilvemark, Johan F K F; Bolstad, Nils; Warren, David J; Ainsworth, Mark A; Huisinga, Wilhelm; Ben-Horin, Shomron; Kloft, Charlotte; Steenholdt, Casper